1. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?

   • Andrew Leask
   • Sunil K. Parapuram
   • D. J. Abraham

   Review Open access 21 January 2009 Pages: 89 - 94

   

2. Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

   • Roger M. Mason

   Review Open access 14 February 2009 Pages: 95 - 104

3. Normal growth and development in mice over-expressing the CCN family member WISP3

   • Yukio Nakamura
   • Yajun Cui
   • Matthew L. Warman

   Research Article Open access 29 April 2009 Pages: 105 - 113

   

4. CCN3: a key growth regulator in Chronic Myeloid Leukaemia

   • Lynn McCallum
   • Wanhua Lu
   • Alexandra E. Irvine

   OriginalPaper Open access 22 July 2009 Pages: 115 - 124

   

5. Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair

   • Linda Jackson-Boeters
   • Weiyan Wen
   • Douglas W. Hamilton

   Research Article Open access 19 June 2009 Pages: 125 - 133

   

6. CCN3 and bone marrow cells

   • Ken-ichi Katsube
   • Saki Ichikawa
   • Akira Yamaguchi

   OriginalPaper Open access 23 July 2009 Pages: 135 - 145

   

7. A rapid and sensitive method for measuring cell adhesion

   • Wanhua Lu
   • Lynn McCallum
   • Alexandra E. Irvine

   Research Article Open access 16 April 2009 Pages: 147 - 149

   

8. What’s in an intron? CCN1 mRNA splicing in cancer

   • Andrew Leask

   Bits and Bytes Open access 21 April 2009 Pages: 151 - 152

9. Alternative splicing of CCN mRNAs …. it has been upon us

   • Bernard Perbal

   Bits and Bytes Open access 28 April 2009 Pages: 153 - 157

   

10. Death of a tumor: targeting CCN in pancreatic cancer

    • Andrew Leask

    Bits and Bytes Open access 08 March 2009 Pages: 159 - 160

11. Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2

    • Andrew Leask

    Bits and Bytes Open access 29 May 2009 Pages: 161 - 162